Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential

by Catherine Delbaldo, Sandrine Faivre, Chantal Dreyer, Eric Raymond
Published 2012-01-01

Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine Compound

by Sandrine Faivre, Eric Raymond, José Jimeno, Miguel Aracil, Ivan Bieche, Carlos Maria Galmarini, Maria Eugenia Riveiro, Maria Serova, Armand de Gramont
Published 2013-03-01

Multimodal strategy for the management of sphenoid osteoradionecrosis: Preliminary results

by Hannah Daoudi, Marc A. Labeyrie, Sophie Guillerm, Sylvie Delanian, Jean‐Pierre Guichard, Clément Jourdaine, Sandrine Faivre, Helene Gauthier, François‐Régis Ferrand, Benjamin Verillaud, Philippe Herman
Published 2020-02-01

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

by Sara I. Pai, Sandrine Faivre, Lisa Licitra, Jean-Pascal Machiels, Jan B. Vermorken, Paolo Bruzzi, Viktor Gruenwald, Raul E. Giglio, C. René Leemans, Tanguy Y. Seiwert, Denis Soulieres
Published 2019-04-01

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

by Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre
Published 2021-01-01

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

by Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre
Published 2020-01-01